USFDA issues Form 483 with 10 observations to Bioconâs Bangalore plant News News / News 7 years ago 544 Views comments Regulatory woes continue for Biocon. The United States Foods and Drug Administration (USFDA) issued a form 483 with 10 observations to the Bangalore p... Read more
News Cadila Healthcare: Zydus Pharmaceuticals subsidiary gets USFDA approval News / News - 7 years ago
News Storyboard: Here#39;s an exclusive conversation with Tham Khai Meng of OM Worldwide News / News - 7 years ago
Comments